Prevent children from opening bottles to help pharmaceutical companies break through

Recently, the State Food and Drug Administration passed the priority review and approval procedure and conditionally approved the listing of the Class 1 innovative drug vometinib mesylate (trade name: Ivesa) declared by Shanghai Ailisi Pharmaceutical Technology Co., Ltd., which is also The second domestically produced Class 1 new chemical drug approved for marketing this year.

The drug is the third representative EGFR kinase inhibitor, and is an innovative drug independently researched and developed by my country with independent intellectual property rights. Applicable to the disease progression during or after treatment with previous epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), and the presence of locally advanced or metastatic non-small cell lung cancer with positive EGFR T790M mutation confirmed by testing ( NSCLC) treatment of adult patients.

The launch of this drug will bring new choices for lung cancer patients, and competition in the lung cancer drug market will also become more intense. Innovation is the foundation of enterprise development. Pharmaceutical companies must continue to innovate and develop new drugs that meet market needs if they want to survive in the ever-changing market. In addition, pharmaceutical packaging also needs continuous innovation. At present, some anti-cancer drugs, high blood pressure and other drugs mostly use the special packaging method of preventing children from opening the bottle, in order to find a breakthrough in the fierce market competition.

child proof bottle

The main function of the child-proof bottle is to prevent children from opening the pharmaceutical packaging and accidentally ingesting drugs. The United States has implemented the Poison Prevention Packaging Act (PPPA) as early as 1970, requiring certain products that are potentially threatening to children to use child-proof packaging. More and more developed countries are implementing it. With the continuous innovation of medicines and people's attention to the problem of children's accidental ingestion of medicines, child-proof bottles will be applied to more medicine packaging, to a certain extent, to help companies establish a good brand image and improve product competitiveness.